info@mail.ucallm.com
From Organelle Quality Control to Cellular Adaptation — Empowering Comprehensive Autophagy Research with Validated Antibody Solutions
Selective autophagy is an essential cellular quality-control mechanism that maintains organelle integrity, proteostasis, metabolic balance, and cellular homeostasis through the targeted recognition and degradation of damaged or unnecessary cellular components.Unlike bulk autophagy, selective autophagy employs specialized cargo receptors, ubiquitin signaling pathways, and autophagosome formation machinery to selectively remove specific intracellular substrates, including mitochondria, endoplasmic reticulum, peroxisomes, lipid droplets, protein aggregates, lysosomes, ribosomes, and invading pathogens.
Dysregulation of selective autophagy contributes to diverse pathological processes, including:
Neurodegenerative disorders
Cancer progression and therapeutic resistance
Metabolic diseases
Aging-associated cellular dysfunction
Inflammatory and infectious diseases
We provide comprehensive antibody solutions for dissecting selective autophagy mechanisms—from autophagy initiation and cargo recognition to organelle-specific degradation pathways, lysosomal processing, and cellular stress adaptation.
Validated antibodies enable researchers to characterize:
- Core autophagy initiation and autophagic flux pathways
- Selective organelle degradation mechanisms
- Mitophagy-mediated mitochondrial quality control
- ER-phagy and proteostasis regulation
- Lysosomal damage sensing and repair
- Metabolic adaptation through lipophagy
- Protein aggregate clearance mechanisms
Selective Autophagy Biomarker Antibody Portfolio
—Comprehensive Solutions for Autophagy Pathway Profiling, Organelle Quality Control Analysis, and Disease Mechanism Discovery
Selective autophagy is regulated by coordinated interactions among autophagy machinery proteins, cargo receptors, ubiquitin modifiers, organelle markers, and lysosomal degradation pathways.
Our antibody portfolio provides validated research tools targeting key selective autophagy mechanisms involved in:
Research Focus | Representative Biomarkers | Research Applications |
Core Autophagy Machinery | LC3A/B, GABARAP, SQSTM1/p62, NBR1, ULK1, Beclin-1, PIK3C3, PIK3R4, ATG5, ATG7, ATG16L1 | Monitoring autophagy initiation, autophagosome formation, and autophagic flux |
Mitophagy & Mitochondrial Quality Control | PINK1, PRKN, p-Ser65-Ubiquitin, BNIP3, BNIP3L, FUNDC1, PHB2, OPTN, CALCOCO2, TAX1BP1, USP30, USP15 | Investigating mitochondrial clearance, stress adaptation, and mitochondrial homeostasis |
ER-phagy & Proteostasis Regulation | RETREG1 , SEC62, RTN3, ATL3, CCPG1, TEX264, TRIM13, CALCOCO1 | Characterizing ER turnover, unfolded protein response, and ER stress recovery |
Pexophagy & Peroxisome Homeostasis | ACBD5, PEX5, PEX2, PEX14, NBR1, USP30 | Studying selective peroxisome degradation and oxidative stress regulation |
Lipophagy & Lipid Metabolism Regulation | PLIN2, PLIN3, RAB7A, ATGL, PNPLA8, HSL, TFEB, TFE3, PPARA, FXR | Investigating lipid droplet turnover and metabolic adaptation |
Ribophagy & Translation Control | NUFIP1, ZNHIT3 | Analysis of ribosome degradation under nutrient stress |
Proteaphagy & Proteostasis Maintenance | RPN1, RPN10, RPN13 | Detection of selective proteasome degradation pathways |
Lysophagy & Lysosomal Quality Control | LGALS3, LGALS8, LGALS9, TRIM16, UBE2QL1, FBXO27, LAMP1, LAMP2, CALCOCO2, SQSTM1 | Monitoring damaged lysosome recognition and repair pathways |
Aggrephagy & Protein Aggregate Clearance | ALFY, TOLLIP, p62/SQSTM1 | Studying aggregate removal mechanisms in neurodegeneration and cancer |
Nucleophagy & Nuclear Quality Control | Lamin B1, Lamin A/C, Emerin | Investigating nuclear component degradation and genome stability |
Xenophagy & Host Defense Autophagy | p62, OPTN, NDP52, NBR1, TAX1BP1, TRIM32 | Characterizing pathogen recognition and innate immune autophagy |
Core Selective Autophagy Targets
—Molecular Regulators of Cargo Recognition, Organelle Clearance, and Lysosomal Degradation
Selective autophagy relies on specialized receptor proteins that connect damaged cellular components with autophagic machinery through LC3/GABARAP interaction domains, ubiquitin recognition, and lysosomal degradation pathways.
Target | Core Biological Function | Antibody Research Application |
LC3A/B | Essential autophagosome membrane protein involved in autophagosome formation and cargo recruitment | WB detection of LC3-I/LC3-II conversion; IF analysis of autophagosome formation; IHC evaluation of tissue autophagy activity |
GABARAP Family | ATG8 family proteins regulating autophagosome maturation and selective cargo recruitment | IF co-staining for selective autophagy pathway activation; autophagic flux analysis |
SQSTM1/p62 | Universal autophagy receptor linking ubiquitinated cargo to LC3/GABARAP proteins | Monitoring selective cargo degradation and autophagic flux |
NBR1 | Cargo receptor involved in selective degradation of protein aggregates and peroxisomes | Detection of pexophagy and aggrephagy pathways |
ULK1 | Core kinase initiating autophagy induction upstream of autophagosome formation | Detection of phosphorylated ULK1 activity and autophagy initiation signaling |
BECN1 (Beclin-1) | Essential regulator of class III PI3K complex formation during autophagy initiation | IF/IHC analysis of autophagy initiation and organelle-associated autophagy |
VPS34 | Catalytic component of class III PI3K complex generating PI3P for autophagosome nucleation | Monitoring early autophagosome formation and pathway activation |
Featured Selective Autophagy Research Panels
—Comprehensive Antibody Panels for Organelle Quality Control, Cellular Stress Response, and Disease Mechanism Discovery
Selective autophagy maintains cellular homeostasis through the targeted elimination of damaged organelles, protein aggregates, and metabolic substrates. Dysregulation of these pathways contributes to mitochondrial dysfunction, cancer progression, neurodegeneration, metabolic disorders, and inflammatory diseases.
Mitophagy Research Panel—Investigating mitochondrial quality control and stress-induced mitochondrial clearance
Key Markers
Mitophagy Initiation | PINK1 | Parkin | Ubiquitin |
Hypoxia-Induced Mitophagy | BNIP3 | NIX | FUNDC1 |
Mitophagy Receptors | OPTN | NDP52 | TAX1BP1 |
Mitochondrial Remodeling | MFN1 | MFN2 | PHB2 |
Negative Regulation | USP30 | USP15 |
|
ER-phagy Research Panel—Understanding endoplasmic reticulum turnover and proteostasis regulation
Key Markers
FAM134B | SEC62 | RTN3 | ATL3 |
CCPG1 | TEX264 | TRIM13 | CALCOCO1 |
Lysophagy Research Panel—Decoding lysosomal damage sensing and membrane repair mechanisms
Key Markers
Galectin-3/8/9 | TRIM16 | UBE2QL1 | FBXO27 | LAMP1 | LAMP2 |
Lipophagy Research Panel—Investigating lipid droplet degradation and metabolic remodeling
Key Markers
ATGL | PNPLA8 | PLIN2/3 | TFEB | TFE3 | PPARα | FXR |
Why Researchers Choose Our Selective Autophagy Antibody Solutions?
Validated Autophagy Targets. Comprehensive Organelle Panels. Reliable Mechanistic Insights.
Our antibody portfolio supports complete selective autophagy research workflows:
Research Challenge | Our Solution |
How can I monitor autophagy activation? | LC3, p62, GABARAP, ULK1 pathway antibodies |
How can I study mitochondrial quality control? | PINK1, Parkin, BNIP3, FUNDC1 mitophagy markers |
How can I investigate organelle-specific autophagy? | ER-phagy, pexophagy, lipophagy, lysophagy marker panels |
How can I analyze autophagic flux? | LC3-II, p62 degradation, receptor-based detection strategies |
How can I study disease-associated autophagy dysfunction? | Neurodegeneration, cancer, metabolism-focused autophagy panels |
How can I perform spatial autophagy profiling? | Multiplex IF/IHC-compatible validated antibody solutions |
Key reference
Narendra D.P., Youle R.J. (2011). Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology. 12: 9–14.
Randow F., MacMicking J.D. (2013). Selective autophagy of pathogens. Nature Reviews Immunology. 13: 325–338.
Singh R., Cuervo A.M. (2009). Autophagy regulates lipid metabolism. Nature. 458: 1131–1135.
Wei Y., Chiang W.C., Sumpter R., Jr., Mishra P., Levine B. (2017). Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor. Cell. 168: 224–238.
Wyant G.A., et al. (2018). NUFIP1 is a ribophagy receptor in mammals. Science. 360: 751–758.
Subramani S. (2015). Pexophagy: molecular mechanisms and disease links. Annual Review of Biochemistry. 84: 659–688.
Khaminets A., et al. (2015). Regulation of endoplasmic reticulum turnover by selective autophagy. Nature. 522: 354–358.
Liu J.X., Wu Y.Y., Meng S., et al. (2024). Selective autophagy in cancer: mechanisms, therapeutic implications. Molecular Cancer. 23: 22.
Zhang H., et al. (2026). Mitophagy in the pathogenesis and management of disease. Cell Research. 36: 11–37.
Molinari M., Rudinskiy M., Galli C., et al. (2025). The intrinsically disordered regions of organellophagy receptors control ER-phagy and mitophagy flux. Nature Cell Biology. 27: 1431–1447.
Palikaras K., Lionaki E., Tavernarakis N. (2018). Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nature Cell Biology. 20: 1013–1022.
Zechner R., et al. (2017). Lipophagy: lipolysis meets autophagy. Cell Metabolism. 25: 1210–1222.